
Vorgun GM 1mg/500mg/0.3mg Tablet SR
Marketer
Daxia Healthcare
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Vorgun GM 1mg/500mg/0.3mg Tablet SR
Diabex Trio (1mg/500mg/0.3mg) extended-release tablets are classified as anti-diabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose levels. Diabex Trio should be administered with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with well-controlled blood sugar, as discontinuation without medical supervision can elevate glucose levels, potentially leading to complications such as kidney impairment, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan encompassing a healthy diet, regular physical activity, and weight management, as directed by your doctor. Lifestyle modifications are integral to diabetes control. Hypoglycemia (low blood sugar) is the most prevalent adverse effect, characterized by symptoms like sweating, lightheadedness, headache, and tremors. Awareness of these signs and prompt treatment with fast-acting glucose (e.g., sugary snacks, fruit juice) is essential. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur in some patients. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.
Primary Ingredients of Vorgun GM 1mg/500mg/0.3mg Tablet SR
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Vorgun GM 1mg/500mg/0.3mg Tablet SR
Managing type 2 diabetes
Major Benefits of Vorgun GM 1mg/500mg/0.3mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Vorgun GM 1mg/500mg/0.3mg Extended-Release tablets on an empty stomach.
Common Side effects of Vorgun GM 1mg/500mg/0.3mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Vorgun GM 1mg/500mg/0.3mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the Vorgun GM 1mg/500mg/0.3mg Tablet SR whole; avoid chewing, crushing, or fracturing. Consume it on an empty stomach.
How Vorgun GM 1mg/500mg/0.3mg Tablet SR works:
Vorgun SR, a sustained-release tablet (1mg/500mg/0.3mg), combines three antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol and Vorgun GM 1mg/500mg/0.3mg SR Tablet use is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Vorgun GM 1mg/500mg/0.3mg SR Tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against potential hazards prior to prescription. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Vorgun GM tablets (1mg/500mg/0.3mg) are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Patients with kidney disease should likely avoid Vorgun GM 1mg/500mg/0.3mg Tablet SR, as its use may be unsafe. Medical advice should be sought before taking this medication. The use of Vorgun GM 1mg/500mg/0.3mg Tablet SR is contraindicated in individuals with severe kidney impairment.
LiverCAUTION
Patients with liver impairment should use Vorgun GM 1mg/500mg/0.3mg SR tablets cautiously, potentially requiring dose modification. Individuals with mild to moderate liver disease typically begin with a reduced Vorgun GM 1mg/500mg/0.3mg SR tablet dosage; however, its use is contraindicated in those with severe hepatic dysfunction. Medical advice is recommended.
What if you forget to take Vorgun GM 1mg/500mg/0.3mg Tablet SR :
Should you forget a Vorgun GM 1mg/500mg/0.3mg Tablet SR dose, take it immediately upon remembering. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take more than the prescribed amount.
Facts to Know About Vorgun GM 1mg/500mg/0.3mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
